0 Evaluaciones
ID

34864

Descripción

Study ID: 101998 Clinical Study ID: 101998 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor GlaxoSmithKline Collaborators N/A Phase Phase 3 Study Recruitment Status Completed Generic Name sumatriptan Trade Name Imitrex ,Imiject ,Imigran Study Indication Migraine Disorders This form contains the conclusion of the study, it should be filled out at the final visit.

Palabras clave

Versiones (2)
  1. 26/1/19 26/1/19 -
  2. 1/2/19 1/2/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

1 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Efficacy and Tolerability of TREXIMA Tablets vs. Placebo During Mild Migraine Study ID 101998

    Inglés

    Study Conclusion

    1 formularios  
    1. StudyEvent: ODM
      1. Study Conclusion
    Administrative Data
    Descripción

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Subject Identifier
    Descripción

    Subject Identifier

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Date of subject completion or withdrawal
    Descripción

    Date of Completion or Withdrawal

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C2983670
    UMLS CUI [2,1]
    C0011008
    UMLS CUI [2,2]
    C0422727
    Study Conclusion
    Descripción

    Study Conclusion

    Alias
    UMLS CUI-1
    C1707478
    UMLS CUI-2
    C0008972
    Was the subject withdrawn from the study?
    Descripción

    If Yes, tick the primary reason for withdrawal

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0422727
    If Yes, tick the primary reason for withdrawal:
    Descripción

    Adverse Event: Record details on the Non-Serious Adverse Events or Serious Adverse Event pages as appropriate. If subject did not meet treatment eligibility criteria, ensure ’Clinically significant screening lab values’ and/or ’Clinically significant screening ECG abnormalities’ are ticked.

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2349954
    UMLS CUI [1,2]
    C0392360
    UMLS CUI [1,3]
    C0008976
    Other, specify
    Descripción

    Other Specification

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0205394
    UMLS CUI [1,2]
    C2348235
    UMLS CUI [2,1]
    C2349954
    UMLS CUI [2,2]
    C0392360
    UMLS CUI [2,3]
    C0008976
    Investigator Comment Log
    Descripción

    Investigator Comment Log

    Alias
    UMLS CUI-1
    C0008961
    UMLS CUI-2
    C0947611
    CRF Page Number if Applicable
    Descripción

    CRF Page Number

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C1704732
    UMLS CUI [1,2]
    C1516308
    Comment
    Descripción

    Only use this form to record explanatory information on anomalies such as missing data, sponsor waiver of inclusion/exclusion criteria, departures from planned investigational product administration or missed visits.

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0947611
    Signature
    Descripción

    Signature

    Alias
    UMLS CUI-1
    C1519316
    I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
    Descripción

    The Investigator is accountable for CRF data. However, the Principal Investigator may delegate CRF signature authority to a medically qualified Sub-investigator (as indicated on the Site Staff Signature Sheet).

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C2346576
    Date
    Descripción

    Date

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C0011008
    Investigator's Name (print)
    Descripción

    Investigator's Name

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C2826892
    Volver a la parte superior de la página

    Similar models

    Study Conclusion

    1 formularios
    1. StudyEvent: ODM
      1. Study Conclusion
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Subject Identifier
    Item
    Subject Identifier
    integer
    C2348585 (UMLS CUI [1])
    Date of Completion or Withdrawal
    Item
    Date of subject completion or withdrawal
    date
    C2983670 (UMLS CUI [1])
    C0011008 (UMLS CUI [2,1])
    C0422727 (UMLS CUI [2,2])
    Item Group
    Study Conclusion
    C1707478 (UMLS CUI-1)
    C0008972 (UMLS CUI-2)
    Item
    Was the subject withdrawn from the study?
    text
    C0422727 (UMLS CUI [1])
    Subject Withdrawal
    Code List
    Was the subject withdrawn from the study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    If Yes, tick the primary reason for withdrawal:
    text
    C2349954 (UMLS CUI [1,1])
    C0392360 (UMLS CUI [1,2])
    C0008976 (UMLS CUI [1,3])
    Reason for Withdrawal
    Code List
    If Yes, tick the primary reason for withdrawal:
    CL Item
    Adverse event (Adverse event)
    CL Item
    Lost to follow-up (Lost to follow-up)
    CL Item
    Protocol violation (Protocol violation)
    CL Item
    Subject decided to withdraw from the study (Subject decided to withdraw from the study)
    CL Item
    Sponsor terminated study (Sponsor terminated study)
    CL Item
    Subject did not have opportunity to treat migraine (Subject did not have opportunity to treat migraine)
    CL Item
    Did not meet treatment eligibility criteria (Did not meet treatment eligibility criteria)
    CL Item
    Clinically significant screening lab values (Clinically significant screening lab values)
    CL Item
    Clinically significant screening ECG abnormalities (Clinically significant screening ECG abnormalities)
    CL Item
    Other (Other)
    Other Specification
    Item
    Other, specify
    text
    C0205394 (UMLS CUI [1,1])
    C2348235 (UMLS CUI [1,2])
    C2349954 (UMLS CUI [2,1])
    C0392360 (UMLS CUI [2,2])
    C0008976 (UMLS CUI [2,3])
    Item Group
    Investigator Comment Log
    C0008961 (UMLS CUI-1)
    C0947611 (UMLS CUI-2)
    CRF Page Number
    Item
    CRF Page Number if Applicable
    text
    C1704732 (UMLS CUI [1,1])
    C1516308 (UMLS CUI [1,2])
    Comment
    Item
    Comment
    text
    C0947611 (UMLS CUI [1])
    Item Group
    Signature
    C1519316 (UMLS CUI-1)
    Investigator's Signature
    Item
    I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
    text
    C2346576 (UMLS CUI [1])
    Date
    Item
    Date
    date
    C0011008 (UMLS CUI [1])
    Investigator's Name
    Item
    Investigator's Name (print)
    text
    C2826892 (UMLS CUI [1])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial